Comparisons
Semaglutide vs Tirzepatide: What Is the Difference?
Semaglutide (often misspelled semiglutide) is a GLP-1 analogue; tirzepatide adds GIP agonism. Structure, receptor bias and the SURMOUNT-5 trial explained.
Semaglutide
Comparisons
Semaglutide vs Tirzepatide: Receptors, Kinetics, SURPASS-2
Semaglutide engages GLP-1 alone; tirzepatide engages GIP and GLP-1. Structure, reported half-lives and the SURPASS-2 head-to-head trial, compared.
Comparisons
Cagrilintide and Semaglutide: The CagriSema Trial Programme
Cagrilintide is a long-acting amylin analogue; semaglutide a GLP-1 receptor agonist. How the co-formulated pair was designed and what its trials measured.
Comparisons
Retatrutide vs Semaglutide: One Receptor or Three
Semaglutide is a selective GLP-1 receptor agonist; retatrutide activates GIP, GLP-1 and glucagon receptors. Structure, half-life and trial endpoints compared.